University of Liverpool leads new £8.2M medicines development fellowship programme: The University of Liverpool is to lead an exciting new MRC-funded medicines career development partnership...
Global Antibiotic Research and Development Partnership: The University of Liverpool and the Global Antibiotic Research and Development Partnership (GARDP) have signed a Memorandum of Understanding to...
Liverpool scientists develop synthetic antibiotics that could save millions of lives: University of Liverpool scientists have taken a significant step towards unlocking the medical potential of...
Meet the finalist | Dr Jonathan Evans RSM Coloproctology Section Presentation title: The Nrf2 inhibitor Brusatol is a potent antitumour agent, and enhances irinotecan cytotoxicity, in an orthotopic...